Skip to main content
Clinical Trials/TCTR20151122001
TCTR20151122001
Completed
未知

The Randomized Controlled Trial Study of the Incidence of Paclitaxel Hypersensitivity Reaction as First Line drug in Gynecologic Cancer Patients between 2 Steroid Premedication Type: Hydrocortisone & dexamethasone VS Dexamethasone alone

none0 sites52 target enrollmentNovember 22, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Gynecologic cancer patients who had not been received paclitaxel therapy.Hypersensitivity reaction
Sponsor
none
Enrollment
52
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 22, 2015
End Date
June 30, 2016
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
none

Eligibility Criteria

Inclusion Criteria

  • 1\.Gynecologic cancer patient who had pathology report
  • 2\.Need paclitaxel therapy
  • 3\.Patient who had not been received paclitaxel
  • 4\.Bone marrow, kidney,and liver were with in normal limit

Exclusion Criteria

  • 1\.allergy to hydrocortisone
  • 2\.patient who had been received paclitaxel
  • 3\.patient who had history of paclitaxel allergy

Outcomes

Primary Outcomes

Not specified

Similar Trials